Institution · FirstString Research (United States)
Most cited papers from FirstString Research (United States)
What are the most cited papers from FirstString Research (United States)?
The most cited paper from FirstString Research (United States) is "Novel therapies for scar reduction and regenerative healing of skin wounds" (Joshua Matthew Rhett, Gautam S. Ghatnekar, Joseph Alexander Palatinus et al., 2008), with 232 citations. Next come "Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide" (166) and "Connexin43 Carboxyl-Terminal Peptides Reduce Scar Progenitor and Promote Regenerative Healing Following Skin Wounding" (136).
Showing 34 of 34 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Novel therapies for scar reduction and regenerative healing of skin wounds Joshua Matthew Rhett, Gautam S. Ghatnekar, Joseph Alexander Palatinus et al. · Trends in biotechnology | 6 Mar 2008 | 232 |
| 2 | Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide Susan F. Murphy, Robin T. Varghese, Samy Lamouille et al. · Cancer Research | 6 Nov 2015 | 166 |
| 3 | Connexin43 Carboxyl-Terminal Peptides Reduce Scar Progenitor and Promote Regenerative Healing Following Skin Wounding Gautam S. Ghatnekar, Michael P. O’Quinn, L. Jane Jourdan et al. · Regenerative Medicine | Mar 2009 | 136 |
| 4 | The Effect of a Connexin43-Based Peptide on the Healing of Chronic Venous Leg Ulcers: A Multicenter, Randomized Trial Gautam S. Ghatnekar, Christina L. Grek, David G. Armstrong et al. · Journal of Investigative Dermatology | 29 Jul 2014 | 111 |
| 5 | Topical administration of a connexin43‐based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial Christina L. Grek, Guru Prasad, Vijay Viswanathan et al. · Wound Repair and Regeneration | 19 Feb 2015 | 95 |
| 6 | Connexin 43-Based Therapeutics for Dermal Wound Healing Jade Montgomery, Gautam S. Ghatnekar, Christina L. Grek et al. · International Journal of Molecular Sciences | 15 Jun 2018 | 73 |
| 7 | Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics Christina L. Grek, Zhi Sheng, Christian C. G. Naus et al. · Current Opinion in Pharmacology | 24 May 2018 | 69 |
| 8 | Targeting the tight junction protein, zonula occludens-1, with the connexin43 mimetic peptide, αCT1, reduces VEGF-dependent RPE pathophysiology Elisabeth Obert, Randy E. Strauss, Carlene S. Brandon et al. · Journal of Molecular Medicine | 28 Jan 2017 | 66 |
| 9 | Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1 Christina L. Grek, Joshua Matthew Rhett, Jaclynn S. Bruce et al. · BMC Cancer | 2 Apr 2015 | 65 |
| 10 | A Multicenter Randomized Controlled Trial Evaluating a Cx43-Mimetic Peptide in Cutaneous Scarring Christina L. Grek, Jade Montgomery, Meenakshi Sharma et al. · Journal of Investigative Dermatology | 14 Nov 2016 | 57 |
| 11 | Development of PLGA nanoparticles for sustained release of a connexin43 mimetic peptide to target glioblastoma cells Rose Roberts, James W.P. Smyth, John W. Will et al. · Materials Science and Engineering C | 12 Sep 2019 | 53 |
| 12 | Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy April Cox, Yves Sagot, Gaël Hédou et al. · Frontiers in Endocrinology | 2 May 2017 | 53 |
| 13 | Connexin 43, breast cancer tumor suppressor: Missed connections? Christina L. Grek, Joshua Matthew Rhett, Jaclynn S. Bruce et al. · Cancer Letters | 15 Feb 2016 | 48 |
| 14 | A synthetic connexin 43 mimetic peptide augments corneal wound healing Keith Moore, Zachary J. Bryant, Gautam S. Ghatnekar et al. · Experimental Eye Research | 20 Jul 2013 | 48 |
| 15 | Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats Azizul Haque, Mollie Capone, Denise D Matzelle et al. · Neurochemical Research | 15 May 2017 | 46 |
| 16 | Cardiac to cancer: Connecting connexins to clinical opportunity Christina L. Grek, Joshua Matthew Rhett, Gautam S. Ghatnekar · FEBS Letters | 4 Mar 2014 | 46 |
| 17 | Impact of the Controlled Release of a Connexin 43 Peptide on Corneal Wound Closure in an STZ Model of Type I Diabetes Keith Moore, Gautam S. Ghatnekar, Robert G. Gourdie et al. · PLoS ONE | 23 Jan 2014 | 46 |
| 18 | A Connexin43 Mimetic Peptide Promotes Regenerative Healing and Improves Mechanical Properties in Skin and Heart Emily L. Ongstad, Michael P. O’Quinn, Gautam S. Ghatnekar et al. · Advances in Wound Care | Mar 2013 | 46 |
| 19 | Connexin 43 confers chemoresistance through activating PI3K Kevin J. Pridham, Farah Shah, Kasen R. Hutchings et al. · Oncogenesis | 12 Jan 2022 | 43 |
| 20 | HSP90 inhibitor RGRN‐305 for oral treatment of plaque‐type psoriasis: efficacy, safety and biomarker results in an open‐label proof‐of‐concept study* Anne Bregnhøj, Katrine Kyd Holstein Thuesen, Thomas Emmanuel et al. · British Journal of Dermatology | 8 Nov 2021 | 40 |
| 21 | FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages Arielle M. Bryan, Jeehyun Karen You, Travis J. McQuiston et al. · Journal of Clinical Investigation | 2 Jun 2020 | 39 |
| 22 | Ab initioevidence for the formation of impurity d3z2−r2 holes in doped La2−xSrxCuO4 Jason K. Perry, Jamil Tahir‐Kheli, William A. Goddard · Physical review. B, Condensed matter | 8 Mar 2002 | 36 |
| 23 | The connexin 43 carboxyl terminal mimetic peptide αCT1 prompts differentiation of a collagen scar matrix in humans resembling unwounded skin Jade Montgomery, William Jamal Richardson, Spencer R. Marsh et al. · The FASEB Journal | 10 Jul 2021 | 28 |
| 24 | The HSP90 inhibitor RGRN‐305 exhibits strong immunomodulatory effects in human keratinocytes Rikke S Hansen, Katrine Kyd Holstein Thuesen, Anne Bregnhøj et al. · Experimental Dermatology | 14 Feb 2021 | 24 |
| 25 | 2‐Methoxyestradiol induced bax phosphorylation and apoptosis in human retinoblastoma cells via p38 MAPK activation Hongbo Min, Gautam S. Ghatnekar, Angela V. Ghatnekar et al. · Molecular Carcinogenesis | 18 Jul 2011 | 22 |
| 26 | Analysis of trans-Resveratrol in Grapes by Micro-High Performance Liquid Chromatography Enguo Fan, Kai Zhang, Sha Jiang et al. · Analytical Sciences | Aug 2008 | 12 |
| 27 | Evaluation of Lung Metastasis in Mouse Mammary Tumor Models by Quantitative Real-time PCR Melissa A. Abt, Christina L. Grek, Gautam S. Ghatnekar et al. · Journal of Visualized Experiments | 29 Jan 2016 | 9 |
| 28 | Cinnamic acid polymer-based monolithic column for capillary electrochromatography Weiying Yan, Ruyu Gao, Zhichao Zhang et al. · Chromatographia | Jun 2003 | 4 |
| 29 | The Connexin 43 Carboxyl Terminal Mimetic Peptide αCT1 Prompts Differentiation of a Collagen Scar Matrix Resembling Unwounded Skin Jade Montgomery, William Jamal Richardson, Joshua Matthew Rhett et al. · bioRxiv (Cold Spring Harbor Laboratory) | 7 Jul 2020 | 3 |
| 30 | Delivery of a Novel Connexin-43 Mimetic Peptide Enhances Wound Healing Keith Moore, Zachary J. Bryant, Adam C. Vandergriff et al. · Microscopy and Microanalysis | Aug 2013 | 3 |
| 31 | Translational Strategies for the Development of a Wound Healing Technology (Idea) from Bench to Bedside Gautam S. Ghatnekar, Tuan A. Elstrom · Methods in molecular biology | 2013 | 2 |
| 32 | Inhibiting Connexin43/Zonula Occludens‐1 Interactions Improves Alcoholic Lung Barrier Function in vivo Lauren A. Jeffers, Carissa C. James, Ryan C. Reed et al. · The FASEB Journal | May 2021 | 0 |
| 33 | Mechanistic Insight into the Effects of the αCT1 Peptide on RPE Cell Integrity in Models of AMD Elisabeth Obert, Gautam S. Ghatnekar, Robert G. Gourdie et al. · Investigative Ophthalmology & Visual Science | 23 Jun 2017 | 0 |
| 34 | Effects of the Act-1 Peptide on Retinal Pigment Epithelial Cell Integrity in Two Mouse Models of Age-Related Macular Degeneration Elisabeth Obert, Gautam S. Ghatnekar, Bäerbel Rohrer · Investigative Ophthalmology & Visual Science | 11 Jun 2015 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.